Stifel Raises Micrus Endovascular Target to $19

Following a meeting with Micrus management where they came away positive on the prospects of Micrus managing to achieve its stated revenue guidance of $84-87 million for fiscal 2010, Stifel Analysts raised their target to $19 from $15. They also indicated that Micrus will be able to drive significant operating margin improvement throughout the remainder of year.